Stibbe's Business Career and Impact Investing Portfolio
From early contributions to aerospace technology to the establishment of global investment funds, Stibbe has built a diverse professional trajectory. His career is characterized by a transition from large-scale infrastructure and engineering projects to a focused commitment to impact investing—the practice of investing in companies to generate positive, measurable social and environmental impact alongside financial returns.
Early Career and Infrastructure Development
Following his military service in 1984, Stibbe began his professional journey at Israel Aircraft Industries. He served as part of an advisory team dedicated to developing systems for the Lavi fighter jet.
In 1985, he co-founded the LR Group. This organization focused on implementing critical projects and establishing essential infrastructures within developing countries. Stibbe remained with the LR Group for over two decades, eventually selling his 33% stake in the company in 2011.
Shortly after leaving LR, Stibbe entered the engineering, procurement, and construction (EPC) sector by acquiring a 35% share of Mitrelli in 2012. Mitrelli operated in fields similar to those of the LR Group. He later exited this venture in 2018, selling all of his shares in the company.
The Shift to Impact Investing and Vital Capital Fund
In 2010, Stibbe established the Vital Capital Fund. This fund represents a strategic shift toward enterprises that aim to enhance the economic, personal, and social wellbeing of communities in low- and middle-income regions. The fund's core strategy is to balance competitive financial returns with a commitment to creating tangible social and environmental benefits.
Beyond his own fund, Stibbe contributes his expertise as a member of the advisory committee for Bridges Israel, an impact investment fund specifically targeting Israeli businesses.
Diverse Partnerships in Technology and Healthcare
Stibbe maintains a broad portfolio of partnerships across several high-tech and medical sectors. His current involvements include:
- HarTech: A company specializing in the development of simulation systems.
- LISOD: The Hospital of Israeli Oncology located in Ukraine.
- Pangea Therapeutics: A digital healthcare firm utilizing computational genomics—the use of computer science to analyze genetic data—to create highly personalized cancer treatments and medications.
- Proprep: An online educational company providing tutorials in STEM (Science, Technology, Engineering, and Mathematics).
Key Facts
- Founding Role: Co-founded the LR Group in 1985.
- Investment Focus: Established Vital Capital Fund in 2010 to support low- and middle-income communities.
- Sector Expertise: Experience spans aerospace, EPC (Engineering, Procurement, and Construction), and digital healthcare.
- Healthcare Innovation: Partner in Pangea Therapeutics, focusing on personalized oncology via genomics.
- Educational Support: Partner in Proprep, a STEM-focused online tutorial provider.
| Organization | Role/Relationship | Primary Focus | Period/Status |
|---|---|---|---|
| Israel Aircraft Industries | Adviser | Lavi fighter jet systems | Started 1984 |
| LR Group | Founder | Infrastructure in developing countries | 1985–2011 |
| Mitrelli | Shareholder (35%) | Engineering, Procurement, and Construction | 2012–2018 |
| Vital Capital Fund | Founder | Social and environmental impact investing | Established 2010 |
| Pangea Therapeutics | Partner | Personalized cancer medications | Active |
Frequently Asked Questions
What is the primary goal of the Vital Capital Fund?
The fund invests in enterprises that aim to improve the economic, personal, and social wellbeing of low- and middle-income communities while achieving competitive financial returns.
What was Stibbe's role at the LR Group?
Stibbe was among the founders of the LR Group in 1985, where he focused on infrastructure projects in developing countries until he sold his 33% share in 2011.
How does Pangea Therapeutics personalize cancer treatment?
Pangea Therapeutics uses computational genomics to develop medications and treatments that are highly personalized to the individual patient.
What is Stibbe's connection to the STEM education sector?
Stibbe is a partner in Proprep, a company that provides online tutorials for STEM (Science, Technology, Engineering, and Mathematics) subjects.
Which aerospace project did Stibbe work on early in his career?
In 1984, Stibbe worked as an adviser at Israel Aircraft Industries on the development of systems for the Lavi fighter jet.